Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.23
+0.31 (0.15%)
AAPL  269.35
-3.60 (-1.32%)
AMD  200.61
-3.07 (-1.51%)
BAC  50.07
-2.23 (-4.26%)
GOOG  308.10
+0.95 (0.31%)
META  644.48
-12.53 (-1.91%)
MSFT  394.04
-7.69 (-1.91%)
NVDA  181.14
-3.75 (-2.03%)
ORCL  145.41
-4.90 (-3.26%)
TSLA  402.58
-6.00 (-1.47%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.